In a study done by Alyssa M. Taylor-LaPole, Helen C. Funny, and Keith R. Shockley from Virginia Wesleyan University and published by the Journal of Young Investigators, these questions were put to the test by analyzing the body weights of rodents among normal and non-normal populations, testing the power of our trusty parametric testing system against the statistical assumption of normality.

In a paper published in this issue of the Journal of Young Investigators, Sie and coworkers analyzed single-cell RNA sequencing (scRNA-seq) datasets from Stewart et al. Using bioinformatics tools, Sie et al. aim to shed insights on the possible therapeutic targets for resistant SCLC — a condition defined as SCLC relapse that occurs within 60 days after first-line treatment.